EGFR inhibitors such as Erbitux and Gilotrif show potential in laboratory and mouse studies in treating melanoma with a ...

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

Biomarker-targeted adjuvant therapy improved survival in early-stage NSCLC, highlighting the importance of testing and ...

Breast cancer is the most prevalent malignancy among women worldwide. Phototheranostics—an approach that uses light both to ...

Jazz Pharmaceuticals (JAZZ) stock gains as its lung cancer therapy Zepzelca, in combination with Roche's Tecentriq, receives ...

OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, has selected EVERSANA®, a leading provider ...

Black Diamond Therapeutics's novel EGFR inhibitor shows promise in addressing resistance mutations in NSCLC and glioblastoma.

Oncologists choose amivantamab in combination with lazertinib or chemotherapy in the treatment of patients with advanced NSCLC with EGFR mutations. Improving survival and quality of life for patients ...

the blood tests had been rolled out across the country for suspected lung cancer and advanced breast cancer patients. It said it would help reduce the time taken for people to access targeted ...

EGFR-mutant lung cancer is a rapidly evolving disease landscape ... Intensification strategies, for example, aim to enhance the effectiveness of EGFR-targeted therapies by combining TKIs with other ...

Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous ...